Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1991 Mar 1;173(3):619–628. doi: 10.1084/jem.173.3.619

Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A?

PMCID: PMC2118809  PMID: 1997649

Abstract

In this report we have approached two questions relating to the mechanism of action of cyclosporin A (CsA). First, we address whether the major cytosolic protein for CsA, cyclophilin, is directly involved in mediating the immunosuppressive activity of this drug, and, in particular, whether inhibition of this protein's peptidyl-prolyl cis- trans isomerase (PPIase) activity results in inhibition of murine T cell activation. Second, we ask whether the nephrotoxicity observed with CsA is related to inhibition of PPIase-dependent pathways in cells other than lymphocytes. Using a series of 61 cyclosporin analogues, we generally found a good correlation between cyclophilin binding and immunosuppressive activity for the majority of analogues analyzed. However, a number of compounds of distinct structural classes were found that could interact with cyclophilin but were much less immunosuppressive than expected. The inability of these analogues to inhibit lymphocyte activation could not be explained by their failure to enter the cell and bind to cyclophilin under the conditions used in the cellular assays. Surprisingly, a nonimmunosuppressive analogue, MeAla-6, which bound well to cyclophilin and was active as a PPIase inhibitor, did not induce renal pathology in vivo. Furthermore, another analogue, MeBm2t, which was immunosuppressive in vitro, possessed little or no activity as a PPIase inhibitor. These findings pose serious questions concerning a direct role of cyclosporin in mediating CsA's immunosuppressive and nephrotoxic activities. In addition, they raise doubts about whether PPIase has a direct function in lymphocyte signal transduction.

Full Text

The Full Text of this article is available as a PDF (1.0 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aebi J. D., Deyo D. T., Sun C. Q., Guillaume D., Dunlap B., Rich D. H. Synthesis, conformation, and immunosuppressive activities of three analogues of cyclosporin A modified in the 1-position. J Med Chem. 1990 Mar;33(3):999–1009. doi: 10.1021/jm00165a018. [DOI] [PubMed] [Google Scholar]
  2. Bach J. F. Cyclosporine in autoimmune diseases. Transplant Proc. 1989 Jun;21(3 Suppl 1):97–113. [PubMed] [Google Scholar]
  3. Benigni A., Chiabrando C., Piccinelli A., Perico N., Gavinelli M., Furci L., Patino O., Abbate M., Bertani T., Remuzzi G. Increased urinary excretion of thromboxane B2 and 2,3-dinor-TxB2 in cyclosporin A nephrotoxicity. Kidney Int. 1988 Aug;34(2):164–174. doi: 10.1038/ki.1988.162. [DOI] [PubMed] [Google Scholar]
  4. Bijsterbosch M. K., Klaus G. G. Cyclosporine does not inhibit mitogen-induced inositol phospholipid degradation in mouse lymphocytes. Immunology. 1985 Nov;56(3):435–440. [PMC free article] [PubMed] [Google Scholar]
  5. Blair J. T., Thomson A. W., Whiting P. H., Davidson R. J., Simpson J. G. Toxicity of the immune suppressant cyclosporin A in the rat. J Pathol. 1982 Oct;138(2):163–178. doi: 10.1002/path.1711380206. [DOI] [PubMed] [Google Scholar]
  6. Buss W. C., Stepanek J., Bennett W. M. A new proposal for the mechanism of cyclosporine A nephrotoxicity. Inhibition of renal microsomal protein chain elongation following in vivo cyclosporine A. Biochem Pharmacol. 1989 Nov 15;38(22):4085–4093. doi: 10.1016/0006-2952(89)90690-4. [DOI] [PubMed] [Google Scholar]
  7. Cirillo R., Triggiani M., Siri L., Ciccarelli A., Pettit G. R., Condorelli M., Marone G. Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. J Immunol. 1990 May 15;144(10):3891–3897. [PubMed] [Google Scholar]
  8. Colombani P. M., Robb A., Hess A. D. Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes. Science. 1985 Apr 19;228(4697):337–339. doi: 10.1126/science.3885394. [DOI] [PubMed] [Google Scholar]
  9. Dumont F. J., Melino M. R., Staruch M. J., Koprak S. L., Fischer P. A., Sigal N. H. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. J Immunol. 1990 Feb 15;144(4):1418–1424. [PubMed] [Google Scholar]
  10. Dumont F. J., Staruch M. J., Koprak S. L., Melino M. R., Sigal N. H. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin. J Immunol. 1990 Jan 1;144(1):251–258. [PubMed] [Google Scholar]
  11. Durette P. L., Boger J., Dumont F., Firestone R., Frankshun R. A., Koprak S. L., Lin C. S., Melino M. R., Pessolano A. A., Pisano J. A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analogues. Transplant Proc. 1988 Apr;20(2 Suppl 2):51–57. [PubMed] [Google Scholar]
  12. Fesik S. W., Gampe R. T., Jr, Holzman T. F., Egan D. A., Edalji R., Luly J. R., Simmer R., Helfrich R., Kishore V., Rich D. H. Isotope-edited NMR of cyclosporin A bound to cyclophilin: evidence for a trans 9,10 amide bond. Science. 1990 Dec 7;250(4986):1406–1409. doi: 10.1126/science.2255910. [DOI] [PubMed] [Google Scholar]
  13. Fidelus R. K., Laughter A. H. Protein kinase activation and the immunosuppressant cyclosporine. Transplantation. 1986 Feb;41(2):187–192. [PubMed] [Google Scholar]
  14. Fischer G., Wittmann-Liebold B., Lang K., Kiefhaber T., Schmid F. X. Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature. 1989 Feb 2;337(6206):476–478. doi: 10.1038/337476a0. [DOI] [PubMed] [Google Scholar]
  15. Freedman R. B. Protein disulfide isomerase: multiple roles in the modification of nascent secretory proteins. Cell. 1989 Jun 30;57(7):1069–1072. doi: 10.1016/0092-8674(89)90043-3. [DOI] [PubMed] [Google Scholar]
  16. Granelli-Piperno A. In situ hybridization for interleukin 2 and interleukin 2 receptor mRNA in T cells activated in the presence or absence of cyclosporin A. J Exp Med. 1988 Nov 1;168(5):1649–1658. doi: 10.1084/jem.168.5.1649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Haendler B., Hofer-Warbinek R., Hofer E. Complementary DNA for human T-cell cyclophilin. EMBO J. 1987 Apr;6(4):947–950. doi: 10.1002/j.1460-2075.1987.tb04843.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Handschumacher R. E., Harding M. W., Rice J., Drugge R. J., Speicher D. W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science. 1984 Nov 2;226(4674):544–547. doi: 10.1126/science.6238408. [DOI] [PubMed] [Google Scholar]
  19. Harding M. W., Galat A., Uehling D. E., Schreiber S. L. A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. Nature. 1989 Oct 26;341(6244):758–760. doi: 10.1038/341758a0. [DOI] [PubMed] [Google Scholar]
  20. Harding M. W., Handschumacher R. E., Speicher D. W. Isolation and amino acid sequence of cyclophilin. J Biol Chem. 1986 Jun 25;261(18):8547–8555. [PubMed] [Google Scholar]
  21. Herold K. C., Lancki D. W., Moldwin R. L., Fitch F. W. Immunosuppressive effects of cyclosporin A on cloned T cells. J Immunol. 1986 Feb 15;136(4):1315–1321. [PubMed] [Google Scholar]
  22. June C. H., Ledbetter J. A., Gillespie M. M., Lindsten T., Thompson C. B. T-cell proliferation involving the CD28 pathway is associated with cyclosporine-resistant interleukin 2 gene expression. Mol Cell Biol. 1987 Dec;7(12):4472–4481. doi: 10.1128/mcb.7.12.4472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Kahan B. D. Cyclosporine. N Engl J Med. 1989 Dec 21;321(25):1725–1738. doi: 10.1056/NEJM198912213212507. [DOI] [PubMed] [Google Scholar]
  24. Kaskel F. J., Devarajan P., Arbeit L. A., Moore L. C. Effects of cyclosporine on renal hemodynamics and autoregulation in rats. Transplant Proc. 1988 Jun;20(3 Suppl 3):603–609. [PubMed] [Google Scholar]
  25. Krönke M., Leonard W. J., Depper J. M., Arya S. K., Wong-Staal F., Gallo R. C., Waldmann T. A., Greene W. C. Cyclosporin A inhibits T-cell growth factor gene expression at the level of mRNA transcription. Proc Natl Acad Sci U S A. 1984 Aug;81(16):5214–5218. doi: 10.1073/pnas.81.16.5214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Lamb F. S., Webb R. C. Cyclosporine augments reactivity of isolated blood vessels. Life Sci. 1987 Jun 29;40(26):2571–2578. doi: 10.1016/0024-3205(87)90080-4. [DOI] [PubMed] [Google Scholar]
  27. Merker M. P., Merker M. M., Handschumacher R. E. Uptake and nature of the intracellular binding of cyclosporin A in a murine thymoma cell line, BW5147. J Immunol. 1984 Jun;132(6):3064–3070. [PubMed] [Google Scholar]
  28. Moss N. G., Powell S. L., Falk R. J. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats. Proc Natl Acad Sci U S A. 1985 Dec;82(23):8222–8226. doi: 10.1073/pnas.82.23.8222. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Quesniaux V. F., Schreier M. H., Wenger R. M., Hiestand P. C., Harding M. W., Van Regenmortel M. H. Cyclophilin binds to the region of cyclosporine involved in its immunosuppressive activity. Eur J Immunol. 1987 Sep;17(9):1359–1365. doi: 10.1002/eji.1830170921. [DOI] [PubMed] [Google Scholar]
  30. Russell D. H., Matrisian L., Kibler R., Larson D. F., Poulos B., Magun B. E. Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem Biophys Res Commun. 1984 Jun 29;121(3):899–906. doi: 10.1016/0006-291x(84)90762-9. [DOI] [PubMed] [Google Scholar]
  31. Schneuwly S., Shortridge R. D., Larrivee D. C., Ono T., Ozaki M., Pak W. L. Drosophila ninaA gene encodes an eye-specific cyclophilin (cyclosporine A binding protein). Proc Natl Acad Sci U S A. 1989 Jul;86(14):5390–5394. doi: 10.1073/pnas.86.14.5390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Siekierka J. J., Staruch M. J., Hung S. H., Sigal N. H. FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein, cyclophilin. J Immunol. 1989 Sep 1;143(5):1580–1583. [PubMed] [Google Scholar]
  33. Smeesters C., Chaland P., Giroux L., Moutquin J. M., Etienne P., Douglas F., Corman J., St-Louis G., Daloze P. Prevention of acute cyclosporine A nephrotoxicity by a thromboxane synthetase inhibitor. Transplant Proc. 1988 Apr;20(2 Suppl 2):663–669. [PubMed] [Google Scholar]
  34. Sumpio B. E. Cyclosporine toxicity in the isolated perfused rat kidney. Transplant Proc. 1988 Jun;20(3 Suppl 3):712–716. [PubMed] [Google Scholar]
  35. Takahashi N., Hayano T., Suzuki M. Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature. 1989 Feb 2;337(6206):473–475. doi: 10.1038/337473a0. [DOI] [PubMed] [Google Scholar]
  36. Tocci M. J., Matkovich D. A., Collier K. A., Kwok P., Dumont F., Lin S., Degudicibus S., Siekierka J. J., Chin J., Hutchinson N. I. The immunosuppressant FK506 selectively inhibits expression of early T cell activation genes. J Immunol. 1989 Jul 15;143(2):718–726. [PubMed] [Google Scholar]
  37. Trenn G., Taffs R., Hohman R., Kincaid R., Shevach E. M., Sitkovsky M. Biochemical characterization of the inhibitory effect of CsA on cytolytic T lymphocyte effector functions. J Immunol. 1989 Jun 1;142(11):3796–3802. [PubMed] [Google Scholar]
  38. Triggiani M., Cirillo R., Lichtenstein L. M., Marone G. Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. Int Arch Allergy Appl Immunol. 1989;88(1-2):253–255. doi: 10.1159/000234801. [DOI] [PubMed] [Google Scholar]
  39. Tropschug M., Barthelmess I. B., Neupert W. Sensitivity to cyclosporin A is mediated by cyclophilin in Neurospora crassa and Saccharomyces cerevisiae. Nature. 1989 Dec 21;342(6252):953–955. doi: 10.1038/342953a0. [DOI] [PubMed] [Google Scholar]
  40. Voss B. L., Hamilton K. K., Samara E. N., McKee P. A. Cyclosporine suppression of endothelial prostacyclin generation. A possible mechanism for nephrotoxicity. Transplantation. 1988 Apr;45(4):793–796. doi: 10.1097/00007890-198804000-00025. [DOI] [PubMed] [Google Scholar]
  41. Williams J. W., Morrison J. F. The kinetics of reversible tight-binding inhibition. Methods Enzymol. 1979;63:437–467. doi: 10.1016/0076-6879(79)63019-7. [DOI] [PubMed] [Google Scholar]
  42. Xue H., Bukoski R. D., McCarron D. A., Bennett W. M. Induction of contraction in isolated rat aorta by cyclosporine. Transplantation. 1987 May;43(5):715–718. doi: 10.1097/00007890-198705000-00022. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES